HRP20030610B1 - Process for the preparation of mesylates of piperazine derivatives - Google Patents

Process for the preparation of mesylates of piperazine derivatives

Info

Publication number
HRP20030610B1
HRP20030610B1 HR20030610A HRP20030610A HRP20030610B1 HR P20030610 B1 HRP20030610 B1 HR P20030610B1 HR 20030610 A HR20030610 A HR 20030610A HR P20030610 A HRP20030610 A HR P20030610A HR P20030610 B1 HRP20030610 B1 HR P20030610B1
Authority
HR
Croatia
Prior art keywords
formula
group
hydrogen
alkoxy
alkyl
Prior art date
Application number
HR20030610A
Other languages
English (en)
Croatian (hr)
Inventor
Marcel
Stefanus
Zorgdrager Jan
Michiel
Original Assignee
Solvay Pharmaceuticals B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals B.V. filed Critical Solvay Pharmaceuticals B.V.
Publication of HRP20030610A2 publication Critical patent/HRP20030610A2/xx
Publication of HRP20030610B1 publication Critical patent/HRP20030610B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
HR20030610A 2001-02-16 2003-07-28 Process for the preparation of mesylates of piperazine derivatives HRP20030610B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (2)

Publication Number Publication Date
HRP20030610A2 HRP20030610A2 (en) 2005-06-30
HRP20030610B1 true HRP20030610B1 (en) 2006-02-28

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030610A HRP20030610B1 (en) 2001-02-16 2003-07-28 Process for the preparation of mesylates of piperazine derivatives

Country Status (35)

Country Link
US (1) US7030241B2 (xx)
EP (1) EP1362040B1 (xx)
JP (1) JP4328528B2 (xx)
KR (2) KR100859106B1 (xx)
CN (1) CN1176079C (xx)
AR (1) AR034206A1 (xx)
AT (1) ATE284875T1 (xx)
AU (1) AU2002250962B2 (xx)
BG (1) BG66101B1 (xx)
BR (1) BR0205683A (xx)
CA (1) CA2422703C (xx)
CZ (1) CZ301780B6 (xx)
DE (1) DE60202261T2 (xx)
DK (1) DK1362040T3 (xx)
DZ (1) DZ3489A1 (xx)
ES (1) ES2230481T3 (xx)
HK (1) HK1059934A1 (xx)
HR (1) HRP20030610B1 (xx)
HU (1) HUP0400772A3 (xx)
IL (1) IL153509A (xx)
IS (1) IS2417B (xx)
ME (1) MEP37508A (xx)
MX (1) MXPA03002359A (xx)
MY (1) MY130687A (xx)
NO (1) NO324460B1 (xx)
NZ (1) NZ524632A (xx)
PL (1) PL208363B1 (xx)
PT (1) PT1362040E (xx)
RS (1) RS51126B (xx)
RU (1) RU2272036C2 (xx)
SI (1) SI1362040T1 (xx)
SK (1) SK286143B6 (xx)
UA (1) UA75390C2 (xx)
WO (1) WO2002066449A2 (xx)
ZA (1) ZA200301590B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) * 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) * 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
BRPI0715445A2 (pt) 2006-08-31 2014-05-13 Solvay Pharm Bv Uso de um composto de bifeprunox, e, kit de titulação
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
WO2009100258A1 (en) 2008-02-05 2009-08-13 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical solid state forms
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32935A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Polimorfos de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (en) 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
PT889889E (pt) * 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
WO2002066449A3 (en) 2002-10-24
NO324460B1 (no) 2007-10-22
DZ3489A1 (fr) 2002-08-29
IS6876A (is) 2003-07-17
HK1059934A1 (en) 2004-07-23
PL208363B1 (pl) 2011-04-29
MEP37508A (en) 2011-02-10
JP2004518741A (ja) 2004-06-24
HUP0400772A2 (hu) 2004-08-30
DE60202261D1 (de) 2005-01-20
PT1362040E (pt) 2005-05-31
CN1176079C (zh) 2004-11-17
JP4328528B2 (ja) 2009-09-09
EP1362040B1 (en) 2004-12-15
CA2422703A1 (en) 2002-08-29
BR0205683A (pt) 2004-07-06
DK1362040T3 (da) 2005-01-24
ES2230481T3 (es) 2005-05-01
CA2422703C (en) 2010-04-13
CZ301780B6 (cs) 2010-06-23
ATE284875T1 (de) 2005-01-15
RS51126B (sr) 2010-10-31
MY130687A (en) 2007-07-31
AR034206A1 (es) 2004-02-04
NO20031754D0 (no) 2003-04-15
AU2002250962B2 (en) 2006-08-24
HUP0400772A3 (en) 2008-02-28
DE60202261T2 (de) 2005-05-19
NO20031754L (no) 2003-04-15
BG66101B1 (bg) 2011-04-29
SK3092003A3 (en) 2003-09-11
CN1463268A (zh) 2003-12-24
IL153509A0 (en) 2003-07-06
KR20030077523A (ko) 2003-10-01
ZA200301590B (en) 2004-02-05
SK286143B6 (sk) 2008-04-07
HRP20030610A2 (en) 2005-06-30
IL153509A (en) 2007-12-03
US20040077631A1 (en) 2004-04-22
KR101000733B1 (ko) 2010-12-14
IS2417B (is) 2008-10-15
UA75390C2 (en) 2006-04-17
YU64403A (sh) 2006-05-25
SI1362040T1 (en) 2005-06-30
BG108090A (bg) 2004-12-30
EP1362040A2 (en) 2003-11-19
US7030241B2 (en) 2006-04-18
MXPA03002359A (es) 2003-06-30
KR20080064206A (ko) 2008-07-08
KR100859106B1 (ko) 2008-09-18
RU2272036C2 (ru) 2006-03-20
WO2002066449A2 (en) 2002-08-29
CZ2003697A3 (cs) 2003-06-18
NZ524632A (en) 2004-03-26
PL369330A1 (en) 2005-04-18

Similar Documents

Publication Publication Date Title
CY1107221T1 (el) Παραγωγα τριαζολιου ως ανταγωνιστες υποδοχεα ταχυκινινης
HUP0400326A2 (hu) Orexin receptor antagonistákként alkalmazható ciklikus N-(aril-karbonil)-amin-származékok és ezeket tartalmazó gyógyszerkészítmények
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
RS51085B (sr) Derivati dioksan-2-alkilkarbamata, postupak za njihovo dobijanje i primena istih u terapeuticima
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
RS50378B (sr) N-heterociklični derivati kao nos inhibitori
RS52546B (en) 1H-BENZIMIDAZOL-4-CARBOXAMIDES SUBSTITUTED WITH QUATERNERN CARBON AT POSITION-2 ARE POWERFUL PARP INHIBITORS
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
RS50932B (sr) N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora
AR011623A1 (es) Compuestos de sulfonamidas, procedimiento para prepararlos y composiciones farmaceuticas para potenciar las funciones de los glutamatoreceptores enmamiferos.
RS53061B (en) INHIBITORI PROTEIN KINAZE
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
UY26727A1 (es) Derivados de tropano útiles en terapia
RS50519B (sr) Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
HRP20040429B1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
YU46787B (sh) Derivati heteroaril 3-okso-propan-nitrila i postupak za njihovo dobijanje
HRP20110785T8 (en) Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren

Legal Events

Date Code Title Description
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120209

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20130215